Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
5.06M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
130K
-
Shares change
-
+50.6K
-
Total reported value, excl. options
-
$187K
-
Value change
-
+$49K
-
Number of buys
-
5
-
Number of sells
-
-3
-
Price
-
$1.44
Significant Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q2 2025
14 filings reported holding SBFM - Sunshine Biopharma Inc. - Common Stock, $0.001 par value as of Q2 2025.
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 130K shares
of 5.06M outstanding shares and own 2.57% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (63.4K shares), RENAISSANCE TECHNOLOGIES LLC (54.1K shares), SBI Securities Co., Ltd. (6.69K shares), MORGAN STANLEY (3.83K shares), SABBY MANAGEMENT, LLC (1.56K shares), UBS Group AG (206 shares), OSAIC HOLDINGS, INC. (152 shares), NATIONAL BANK OF CANADA /FI/ (10 shares), BANK OF AMERICA CORP /DE/ (5 shares), and Federation des caisses Desjardins du Quebec (1 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.